-
|
GLTO
|
Galecto, Inc. Common Stock
|
XNAS |
CS
|
$6.56M |
-
|
GNLX
|
Genelux Corporation Common Stock
|
XNAS |
CS
|
$204.73M |
-
|
GBIO
|
Generation Bio Co. Common Stock
|
XNAS |
CS
|
$34.43M |
-
|
GNPX
|
Genprex, Inc. Common Stock
|
XNAS |
CS
|
$6.87M |
-
|
GOVX
|
GeoVax Labs, Inc. New
|
XNAS |
CS
|
$15.26M |
-
|
GERN
|
Geron Corp
|
XNAS |
CS
|
$682.68M |
-
|
GOSS
|
Gossamer Bio, Inc. Common Stock
|
XNAS |
CS
|
$546.24M |
|
-
|
GRCE
|
Grace Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$45.37M |
-
|
GLSI
|
Greenwich LifeSciences, Inc.
|
XNAS |
CS
|
$119.98M |
-
|
GRI
|
GRI Bio, Inc. Common Stock
|
XNAS |
CS
|
$4.23M |
-
|
GTBP
|
GT Biopharma Inc. Common Stock
|
XNAS |
CS
|
$6.59M |
-
|
GYRE
|
Gyre Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$654.86M |
-
|
HRMY
|
Harmony Biosciences Holdings, Inc. Common Stock
|
XNAS |
CS
|
$1.81B |
-
|
HROW
|
Harrow, Inc. Common Stock
|
XNAS |
CS
|
$1.26B |
-
|
HCWB
|
HCW Biologics Inc. Common Stock
|
XNAS |
CS
|
$6.50M |
-
|
HRTX
|
Heron Therapeutics, Inc.
|
XNAS |
CS
|
$201.70M |
-
|
HOTH
|
Hoth Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$16.31M |
-
|
HYPD
|
Hyperion DeFi, Inc. Common Stock
|
XNAS |
CS
|
$63.57M |
-
|
IBIO
|
iBio, Inc. Common Stock
|
XNAS |
CS
|
$26.74M |
-
|
IDYA
|
IDEAYA Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$2.65B |
-
|
IGC
|
IGC Pharma, Inc.
|
XASE |
CS
|
$33.83M |
-
|
IMMX
|
Immix Biopharma, Inc. Common Stock
|
XNAS |
CS
|
$104.06M |
-
|
IMRX
|
Immuneering Corporation Class A Common Stock
|
XNAS |
CS
|
$435.71M |
-
|
IMUX
|
Immunic, Inc. Common Stock
|
XNAS |
CS
|
$70.89M |
-
|
IMNM
|
Immunome, Inc.
|
XNAS |
CS
|
$1.40B |
-
|
IBO
|
Impact BioMedical, Inc.
|
XASE |
CS
|
$6.71M |
-
|
IMNN
|
Imunon, Inc. Common Stock
|
XNAS |
CS
|
$10.08M |
-
|
IXHL
|
Incannex Healthcare Limited American Depositary Shares
|
XNAS |
ADRC
|
$121.14M |
-
|
INDP
|
Indaptus Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$2.81M |
-
|
INDV
|
Indivior PLC Ordinary Shares
|
XNAS |
CS
|
$3.91B |
-
|
INM
|
InMed Pharmaceuticals Inc. Common Shares
|
XNAS |
CS
|
$3.81M |
|
-
|
UNOV
|
Innovator U.S. Equity Ultra Buffer ETF - November
|
BATS |
ETF
|
- |
-
|
INVA
|
Innoviva, Inc. Common Stock
|
XNAS |
CS
|
$1.56B |
-
|
INO
|
Inovio Pharmaceuticals, Inc.
|
XNAS |
CS
|
$112.66M |
-
|
INSM
|
Insmed, Inc.
|
XNAS |
CS
|
$40.46B |
-
|
IOBT
|
IO Biotech, Inc. Common Stock
|
XNAS |
CS
|
$59.40M |
-
|
IONS
|
Ionis Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$11.91B |
-
|
IRWD
|
Ironwood Pharmaceuticals, Inc. - Class A
|
XNAS |
CS
|
$311.87M |
-
|
ITRM
|
Iterum Therapeutics plc Ordinary Share
|
XNAS |
CS
|
$29.07M |
|
-
|
JBIO
|
Jade Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$422.69M |
-
|
JAGX
|
Jaguar Health, Inc.
|
XNAS |
CS
|
$6.60M |
-
|
JANX
|
Janux Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.59B |
-
|
JAZZ
|
Jazz Pharmaceuticals, Inc.
|
XNAS |
CS
|
$7.97B |
-
|
JNJ
|
Johnson & Johnson
|
XNYS |
CS
|
$449.50B |
-
|
DERM
|
Journey Medical Corporation Common Stock
|
XNAS |
CS
|
$239.68M |
-
|
JUNS
|
Jupiter Neurosciences, Inc. Common Stock
|
XNAS |
CS
|
$46.33M |
-
|
KAPA
|
Kairos Pharma, Ltd.
|
XASE |
CS
|
$17.69M |
-
|
KALA
|
KALA BIO, Inc. Common Stock
|
XNAS |
CS
|
$5.01M |
-
|
KALV
|
KalVista Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$544.64M |
-
|
KPTI
|
Karyopharm Therapeutics Inc.
|
XNAS |
CS
|
$87.98M |
-
|
KZIA
|
Kazia Therapeutics Limited American Depositary Shares
|
XNAS |
ADRC
|
$12.25M |
-
|
KROS
|
Keros Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$493.55M |
-
|
KZR
|
Kezar Life Sciences, Inc. Common Stock
|
XNAS |
CS
|
$44.23M |
-
|
KNSA
|
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
|
XNAS |
CS
|
$2.91B |
-
|
KPRX
|
Kiora Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$8.00M |
-
|
KRRO
|
Korro Bio, Inc. Common Stock
|
XNAS |
CS
|
$317.79M |
-
|
KURA
|
Kura Oncology, Inc.
|
XNAS |
CS
|
$857.99M |
-
|
LTRN
|
Lantern Pharma Inc. Common Stock
|
XNAS |
CS
|
$36.93M |
-
|
LRMR
|
Larimar Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$296.14M |
-
|
LVTX
|
LAVA Therapeutics N.V. Ordinary Shares
|
XNAS |
CS
|
$42.35M |
|
-
|
LBRX
|
LB Pharmaceuticals Inc Common Stock
|
XNAS |
CS
|
$344.50M |
-
|
LPTX
|
Leap Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$25.96M |
-
|
LEXX
|
Lexaria Bioscience Corp. Common Stock
|
XNAS |
CS
|
$23.11M |
-
|
LEXXW
|
Lexaria Bioscience Corp. Warrant
|
XNAS |
WARRANT
|
- |
|
-
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
XNAS |
CS
|
$454.25M |
-
|
LFCR
|
Lifecore Biomedical, Inc. Common Stock
|
XNAS |
CS
|
$256.64M |
-
|
LFVN
|
Lifevantage Corporation Common Stock (Delaware)
|
XNAS |
CS
|
$93.99M |
-
|
LGND
|
Ligand Pharmaceuticals Inc.
|
XNAS |
CS
|
$3.95B |
-
|
LPCN
|
Lipocine Inc.
|
XNAS |
CS
|
$13.76M |
|
-
|
LQDA
|
Liquidia Corporation Common Stock
|
XNAS |
CS
|
$2.27B |
-
|
LSTA
|
Lisata Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$18.04M |
|
-
|
LITS
|
Lite Strategy, Inc. Common Stock
|
XNAS |
CS
|
$74.88M |
-
|
LIXT
|
Lixte Biotechnology Holdings, Inc. Common Stock
|
XNAS |
CS
|
$24.24M |
-
|
LIXTW
|
Lixte Biotechnology Holdings, Inc. Warrants
|
XNAS |
WARRANT
|
- |
-
|
LGVN
|
Longeveron Inc. Common Stock
|
XNAS |
CS
|
$15.72M |
-
|
LNAI
|
Lunai Bioworks Inc. Common Stock
|
XNAS |
CS
|
$21.63M |
-
|
LYEL
|
Lyell Immunopharma, Inc. Common Stock
|
XNAS |
CS
|
$336.39M |
-
|
MGNX
|
MacroGenics, Inc.
|
XNAS |
CS
|
$86.59M |
-
|
MDGL
|
Madrigal Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$11.11B |
-
|
MAIA
|
MAIA Biotechnology, Inc.
|
XASE |
CS
|
$36.95M |
-
|
MNKD
|
Mannkind Corporation
|
XNAS |
CS
|
$1.73B |
-
|
MRVI
|
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
XNAS |
CS
|
$415.23M |
-
|
MRKR
|
Marker Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$11.19M |
-
|
MTNB
|
Matinas BioPharma Holdings, Inc.
|
XASE |
CS
|
$7.11M |
-
|
MBX
|
MBX Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$1.15B |
-
|
MNOV
|
Medicinova, Inc.
|
XNAS |
CS
|
$69.65M |
-
|
MDCX
|
Medicus Pharma Ltd. Common Stock
|
XNAS |
CS
|
$51.28M |
-
|
MDCXW
|
Medicus Pharma Ltd. Warrant
|
XNAS |
WARRANT
|
- |
-
|
MRK
|
Merck & Co., Inc.
|
XNYS |
CS
|
$214.15B |
-
|
MREO
|
Mereo BioPharma Group plc American Depositary Shares
|
XNAS |
ADRC
|
$286.37M |
-
|
MRSN
|
Mersana Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$41.97M |
|
-
|
MRUS
|
Merus N.V. Common Shares
|
XNAS |
CS
|
$7.22B |
-
|
MTVA
|
MetaVia Inc. Common Stock
|
XNAS |
CS
|
$21.98M |
-
|
MTSR
|
Metsera, Inc. Common Stock
|
XNAS |
CS
|
$8.75B |
-
|
MIST
|
Milestone Pharmaceuticals Inc. Common Shares
|
XNAS |
CS
|
$145.34M |
-
|
MLYS
|
Mineralys Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$2.95B |
-
|
NERV
|
Minerva Neurosciences, Inc
|
XNAS |
CS
|
$25.95M |
-
|
MIRA
|
MIRA Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$30.40M |
-
|
MIRM
|
Mirum Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$3.50B |
-
|
MBRX
|
Moleculin Biotech, Inc.
|
XNAS |
CS
|
$24.20M |